JENNIFER GRIFFO: Open Payments
NPI 1053931386 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,176 in 21 payments from 7 companies in 2025. Trend: 2023 $4,051 · 2024 $1,317 · 2025 $1,176
Food & beverage: $1,176
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $553 |
| Alnylam Pharmaceuticals Inc. | 7 | $171 |
| BridgeBio Pharma, Inc. | 1 | $138 |
| Actelion Pharmaceuticals US, Inc. | 1 | $114 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $95 |
| CVRx, Inc. | 2 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: CARDIOMEMS, AMVUTTRA, MITRACLIP, Attruby, UPTRAVI, LifeVest, Barostim Neo System, THORATEC HEARTMATE 3 LVAS IMPLANT KIT.
Industry payments across NV — which companies pay providers there.
